Calpain and caspase: Can you tell the difference?

Trends in Neurosciences

Volumn 23, Issue 1, 2000, Pages 20-26

  Wang, Kevin K W ^a  

^a PFIZER INC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CALMODULIN; CALPAIN; CALPASTATIN; CASPASE; CASPASE 3; FODRIN; NICOTINAMIDE ADENINE DINUCLEOTIDE ADENOSINE DIPHOSPHATE RIBOSYLTRANSFERASE; PROTEIN KINASE; SPECTRIN;

APOPTOSIS; CELL LOSS; DEGENERATIVE DISEASE; ENZYME ACTIVE SITE; ENZYME ACTIVITY; HYPOGLYCEMIA; HYPOXIA; METABOLIC INHIBITION; NERVE CELL NECROSIS; NERVE DEGENERATION; PRIORITY JOURNAL; REVIEW;

ANIMALS; APOPTOSIS; BRAIN DISEASES; CALPAIN; CASPASES; CYSTEINE PROTEINASE INHIBITORS; HUMANS; NECROSIS; NEUROPROTECTIVE AGENTS;

EID: 0033956278     PISSN: 01662236     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0166-2236(99)01479-4     Document Type: Review

References (76)

1. Majno G., Joris I. Apoptosis, oncosis, and necrosis. An overview of cell death. Am. J. Pathol. 146:1995;3-15.
2. Linnik M.D.et al. Evidence supporting a role for programmed cell death in focal cerebral ischemia in rats. Stroke. 24:1993;2002-2008.
3. MacManus J.P.et al. Global ischemia can cause DNA fragmentation indicative of apoptosis in rat brain. Neurosci. Lett. 164:1993;89-92.
4. Filipkowski R.K.et al. DNA fragmentation in rat brain after intraperitoneal administration of kainite. NeuroReport. 5:1994;1538-1540.
5. Bonfoco E.et al. Apoptosis and necrosis, two distinct events induced, respectively, by mild and intense insults with N-methyl-D-aspartate or nitric oxide/superoxide in cortical cell cultures. Proc. Natl. Acad. Sci. U. S. A. 92:1995;7162-7166.
6. Rink A.et al. Evidence of apoptotic cell death after experimental traumatic brain injury in the rat. Am. J. Pathol. 147:1995;1575-1583.
7. Emery E.et al. Apoptosis after traumatic human spinal cord injury. J. Neurosurg. 89:1998;911-920.
8. Nicotera P.et al. Neuronal cell death, a demise with different shapes. Trends Pharmacol. Sci. 20:1999;46-51.
9. Heron A.et al. Regional variability in DNA fragmentation after global ischemia evidenced by combined histological and gel electrophoresis observations in the rat brain. J. Neurochem. 61:1993;1973-1976.
10. Nath R.et al. Evidence for activation of caspase 3-like protease in excitotoxin- and hypoxia/hypoglycemia-injured neurons. J. Neurochem. 71:1998;186-195.
11. Pang Z., Geddes J.W. Mechanisms of cell death induced by the mitochondrial toxin 3-nitropropionic acid, acute excitotoxic necrosis and delayed apoptosis. J. Neurosci. 17:1997;3064-3073.
12. Bonfoco E.et al. Cytoskeletal breakdown and apoptosis elicited by NO donors in cerebellar granule cells require NMDA receptor activation. J. Neurochem. 67:1996;2484-2493.
13. Yuen P-W., Wang K.K.W. Calpain inhibitors, novel neuroprotectants and potential anticataractic agents. Drugs Future. 23:1998;741-749.
14. Nath R.et al. Non-erythroid alpha-spectrin breakdown by calpain and interleukin 1β-converting-enzyme-like protease(s) in apoptotic cells, contributory roles of both protease families in neuronal apoptosis. Biochem. J. 319:1996;683-690.
15. Wang K.K.et al. Calmodulin-binding proteins as calpain substrates. Biochem. J. 262:1989;693-706.
16. Carafoli E., Molinari M. Calpain, a protease in search of a function? Biochem. Biophys. Res. Commun. 2457:1998;193-203.
17. Nicholson D.W., Thornberry N.A. Caspases, killer proteases. Trends Biochem. Sci. 22:1997;299-306.
18. Deveraux Q.L., Reed J.C. IAP family proteins - suppressors of apoptosis. Genes Dev. 13:1999;239-252.
19. McGinnis K.M. Alternations of extracellular calcium elicit selective modes of cell death and protease activation in SH-SY5Y human neuroblastoma cells. J. Neurochem. 72:1999;1853-1863.
20. Juan T.S.et al. Identification and mapping of Casp7, a cysteine protease resembling CPP32 beta, interleukin-1β converting enzyme, and CED 3. Genomics. 40:1997;86-93.
21. Kuida K.et al. Decreased apoptosis in the brain and premature lethality in CPP32-deficient mice. Nature. 384:1996;368-372.
22. Posmantur R.et al. Characterization of CPP32-like protease activity following apoptotic challenge in SH-SY5Y neuroblastoma cells. J. Neurochem. 68:1997;2328-2337.
23. Endres M.et al. Attenuation of delayed neuronal death after mild focal ischemia in mice by inhibition of the caspase family. J. Cereb. Blood Flow Metab. 18:1998;238-247.
24. Yakovlev A.G.et al. Activation of CPP32-like caspases contributes to neuronal apoptosis and neurological dysfunction after traumatic brain injury. J. Neurosci. 17:1997;7415-7424.
25. Schulz J.B.et al. Potassium deprivation-induced apoptosis of cerebellar granule neurons, a sequential requirement for new mRNA and protein synthesis, ICE-like protease activity, and reactive oxygen species. J. Neurosci. 16:1996;4696-4706.
26. Armstrong R.C.et al. Activation of the CED3/ICE-related protease CPP32 in cerebellar granule neurons undergoing apoptosis but not necrosis. J. Neurosci. 17:1997;553-562.
27. Squier M.K.et al. Calpain activation in apoptosis. J. Cell Physiol. 159:1994;229-237.
28. Sarin A.et al. A protease-dependent TCR-induced death pathway in mature lymphocytes. J. Immunol. 154:1995;5806-5812.
29. Nath R.et al. Effects of calpain and ICE-like protease inhibitors on neuronal apoptosis. NeuroReport. 8:1996;249-256.
30. Vanags D.M.et al. Protease involvement in fodrin cleavage and phosphatidylserine exposure in apoptosis. J. Biol. Chem. 271:1996;31075-31085.
31. Squier M.K.et al. Calpain and calpastatin regulate neutrophil apoptosis. J. Cell Physiol. 178:1999;311-319.
32. Brown S.B. Actin is cleaved during constitutive apoptosis. Biochem. J. 323:1997;233-237.
33. Knepper-Nicolai B.et al. Constitutive apoptosis in human neutrophils requires synergy between calpains and the proteasome downstream of caspases. J. Biol. Chem. 273:1998;30530-30536.
34. Wang K.K.W. Simultaneous degradation of αII- and βII-spectrin by caspase 3 (CPP32) in apoptotic cells. J. Biol. Chem. 273:1998;22490-22497.
35. Martin S.J.et al. Proteolysis of fodrin (non-erythroid spectrin) during apoptosis. J. Biol. Chem. 270:1995;6425-6428.
36. Janicke R.U.et al. Caspase 3 is required for α-fodrin cleavage but dispensable for cleavage of other death substrates in apoptosis. J. Biol. Chem. 273:1998;15540-15545.
37. Pike B.R.et al. Regional calpain and caspase 3 proteolysis of alpha-spectrin after traumatic brain injury. NeuroReport. 9:1998;2437-2442.
38. Pike B.R.et al. Temporal relationships between de novo protein synthesis, calpain and caspase 3-like protease activation, and DNA fragmentation during apoptosis in septo-hippocampal cultures. J. Neurosci. Res. 52:1998;505-520.
39. 2+ activated proteinase, degradation of vimentin. Biochem. Biophys. Res. Commun. 116:1983;204-209.
40. Hashimoto M.et al. Rapid fragmentation of vimentin in human skin fibroblasts exposed to tamoxifen, a possible involvement of caspase 3. Biochem. Biophys. Res. Commun. 247:1998;401-406.
41. Prasad S.C.et al. Apoptosis-associated proteolysis of vimentin in human prostate epithelial tumor cells. Biochem. Biophys. Res. Commun. 249:1998;332-338.
42. Ando Y.et al. Purification and characterization of calpains from pig epidermis and their action on epidermal keratin. J. Invest. Dermatol. 90:1988;26-30.
43. Ku N.O.et al. Apoptosis generates stable fragments of human type I keratins. J. Biol. Chem. 272:1997;33197-33203.
44. Mashima T.et al. Identification of actin as a substrate of ICE and an ICE-like protease and involvement of an ICE-like protease but not ICE in VP-16-induced U937 apoptosis. Biochem. Biophys. Res. Commun. 217:1995;1185-1192.
45. Yang F.et al. Antibody to caspase-cleaved actin detects apoptosis in differentiated neuroblastoma and plaque-associated neurons and microglia in Alzheimer's disease. Am. J. Pathol. 152:1998;379-389.
46. 2+-dependent cysteine proteinase, in bovine lens. FEBS Lett. 170:1984;259-262.
47. 2+-dependent proteolysis. J. Neurochem. 65:1995;903-911.
48. Canu N.et al. Tau cleavage and dephosphorylation in cerebellar granule neurons undergoing apoptosis. J. Neurosci. 18:1998;7061-7074.
49. Lazebnik Y.A.et al. Cleavage of poly(ADP-ribose) polymerase by a proteinase with properties like ICE. Nature. 371:1994;346-347.
50. Shah G.M.et al. Different cleavage pattern for poly(ADP-ribose) polymerase during necrosis and apoptosis in HL-60 cells. Biochem. Biophys. Res. Commun. 229:1996;838-844.
51. Sallmann F.R.et al. Characterization of antibodies specific for the caspase cleavage site on poly(ADP-ribose) polymerase, specific detection of apoptotic fragments and mapping of the necrotic fragments of poly(ADP-ribose) polymerase. Biochem. Cell Biol. 75:1997;451-456.
52. Buki K.G. Isolation and identification of a proteinase from calf thymus that cleaves poly(ADP-ribose) polymerase and histone H1. Biochim. Biophys. Acta. 1338:1997;100-106.
53. McGinnis K.M.et al. Pro-caspase-3 and poly(ADP)ribose polymerase (PARP) are calpain substrates. Biochem. Biophys Res. Commun. 263:1999;94-99.
54. 2+/calmodulin-dependent protein kinase IV is cleaved by caspase 3 and calpain in SH-SY5Y human neuroblastoma cells undergoing apoptosis. J. Biol. Chem. 273:1998;19993-20000.
55. 2+/calmodulin-dependent protein kinase II from the post-synaptic density in the rat forebrain. J. Biochem. 119:1996;268-273.
56. Hajimohammadreza I.et al. Neuronal nitric oxide synthase and calmodulin-dependent protein kinase II α undergo neurotoxin-induced proteolysis. J. Neurochem. 69:1997;1006-1013.
57. Cooray P.et al. Focal adhesion kinase (pp125FAK) cleavage and regulation by calpain. Biochem. J. 318:1996;41-47.
58. Wen L.P.et al. Cleavage of focal adhesion kinase by caspases during apoptosis. J. Biol. Chem. 272:1997;26056-26061.
59. Siman R.et al. Proteolytic processing of beta amyloid precursor by calpain I. J. Neurosci. 10:1990;2400-2411.
60. Barnes N.Y.et al. Increased production of amyloid precursor protein provides a substrate for caspase-3 in dying motoneurons. J. Neurosci. 18:1998;5869-5880.
61. Gervais F.G.et al. Involvement of caspases in proteolytic cleavage of Alzheimer's amyloid-β precursor protein and amyloidogenic Aβ peptide formation. Cell. 97:1999;395-406.
62. 2+-dependent neutral protease (calpain). J. Biol. Chem. 264:1989;4088-4092.
63. Ghayur T.et al. Proteolytic activation of protein kinase C delta by an ICE/CED 3-like protease induces characteristics of apoptosis. J. Exp. Med. 184:1996;2399-2404.
64. Datta R.et al. Caspase 3-mediated cleavage of protein kinase C theta in induction of apoptosis. J. Biol. Chem. 272:1997;20317-20320.
65. Banno Y.et al. Endogenous cleavage of phospholipase Cβ3 by agonist-induced activation of calpain in human platelets. J. Biol. Chem. 270:1995;4318-4324.
66. Wissing D.et al. Involvement of caspase-dependent activation of cytosolic phospholipase A2 in tumor necrosis factor-induced apoptosis. Proc. Natl. Acad. Sci. U. S. A. 94:1997;5073-5077.
67. Adam-Klages S.et al. Caspase-mediated inhibition of human cytosolic phospholipase A2 during apoptosis. J. Immunol. 161:1998;5687-5694.
68. Cheng E.H.et al. Conversion of Bcl-2 to a Bax-like death effector by caspases. Science. 278:1997;1966-1968.
69. Wood D.E.et al. Bax cleavage is mediated by calpain during drug-induced apoptosis. Oncogene. 17:1998;1069-1078.
70. McGinnis K.M.et al. Endogenous Bax translocation in SH-SY5Y human neuroblastoma cells and cerebellar granule neurons undergoing apoptosis. J. Neurochem. 72:1999;1899-1906.
71. Mohan P.S., Nixon R.A. Calpain activation and calpastatin processing in cultured human retinoblastoma (Y-79) cells. Soc. Neurosci. Abstr. 22:1996;1918.
72. Wang K.K.W.et al. Caspase-mediated fragmentation of calpain inhibitor protein calpastatin during apoptosis. Arch. Biochem. Biophys. 356:1998;187-196.
73. Porn-Ares M.I., Samali A., Orrenius S. Cleavage of the calpain inhibition, calpastatin, during apotosis. Cell Death Differ. 5:1998;1028-1033.
74. Li P.et al. Mice deficient in IL-1 beta-converting enzyme are defective in production of mature IL-1 beta and resistant to endotoxic shock. Cell. 80:1995;401-411.
75. 2+-activated neutral protease as a processing enzyme of human interleukin 1 alpha. Proc. Natl. Acad. Sci. U. S. A. 87:1990;5548-5552.
76. Markgraf C.G.et al. Six-hour window of opportunity for calpain inhibition in focal cerebral ischemia in rats. Stroke. 29:1998;152-158.